Delivery Order SPE2DB24D2205-SPE2DB24FDYGR
- Not listed
- This $87,940.45 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ELIQUIS 5 MG TABLET 60S. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a range of pharmaceutical products and medical supplies to support military healthcare programs...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,900.08 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical company Amerisourcebergen Corporation. This order is for the supply of ELIQUIS 2.5 mg tablets and is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This is a $21,848.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG tablets. The award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,900.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ELIQUIS 2.5 MG TABLET 60S. This delivery order is part of an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies in support of military treatment programs and facilities...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,120.39, is for the delivery of ELIQUIS 2.5 MG TABLET 60S, which are prescription medications. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a $18,371.82 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This specific...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,851.90 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567732654 ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
- This is a $4,159.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELIQUIS 2.5 MG TABLET 60S, a medication, with a performance period through May 23, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical. The IDC...
- This is a $1,965.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ELIQUIS 2.5 MG TABLET 60S and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This is a $4,577.71 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ELIQUIS 2.5 MG TABLET 60S. The contract has an ultimate completion date of July 10, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDYGRDelivery Order
This $1,900.08 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of ELIQUIS 2.5 MG TABLET 60S. The award is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This particular order does not have a set-aside designation. Amerisourcebergen, through its extensive distribution network, has been a critical supplier of essential pharmaceutical products and medical supplies to various federal agencies and healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/12/24 |